Clinical characteristics | ||
| SLE patients | Normal individuals |
Number | 30 | 30 |
Current age, mean years ± SD | 41.4 ± 11.9 | 39.6 ± 10.2 |
Disease duration, mean years ± SD | 7.88 ±10.6 | N/A |
Female gender, n (%) | 26 (86.7) | 30 (100) |
Organ/system involved | ||
Malar rash, n (%) | 18 (60.0) | N/A |
Photosensitivity, n (%) | 17 (56.7) | N/A |
Hematological, n (%) | 23 (76.6) | N/A |
Renal, n (%) | 13 (43.4) | N/A |
Current antibodies | ||
ANA positive, n (%) | 30 (100) | N/A |
Anti-Sm positive, n (%) | 5 (16.6) | N/A |
Anti-phospholipid (APL) positive, n (%) | 6 (20.0) | N/A |
Anti-M3 synthetic peptide IgG, n (%) | 13 (43.3) | 3 (10.0) |